Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 68071-2890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68071-2890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2890 3)

Pdp (68071 2890 3)
Label for Bupropion Hydrochloride SR 150 mg extended-release tablets by NuCare Pharmaceuticals, Inc. The package contains 30 film-coated tablets, with instructions to take one tablet every 8 hours. The label includes warnings, NDC 68071-2890-3, and notes the tablets are round, purple, biconvex, and debossed with 'SG, 175' on one side. Rx only.*
FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure of bupropion hydrochloride, showing its molecular composition including a chlorophenyl group and tert-butyl ketone moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.